-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I3l2mk71lzueAlqj/XacKu5cqlEjCTu16kg+WLTUHeuohVY46hWAWy18o3hTTJzu zlL6aJyNCKoGYyEEaHx8hQ== 0000950142-10-000820.txt : 20100513 0000950142-10-000820.hdr.sgml : 20100513 20100513184032 ACCESSION NUMBER: 0000950142-10-000820 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100511 FILED AS OF DATE: 20100513 DATE AS OF CHANGE: 20100513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soros Robert CENTRAL INDEX KEY: 0001387524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10830138 MAIL ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS JONATHAN T ALLAN CENTRAL INDEX KEY: 0001387590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10830137 MAIL ADDRESS: STREET 1: C/O SOROS FUND MANAGEMENT LLC STREET 2: 888 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAP Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001401923 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200507047 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-386-3100 MAIL ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS GEORGE CENTRAL INDEX KEY: 0000900203 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10830139 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 33RD FLR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10830136 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: (212) 872-1054 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 4 1 form4_sfmllc051110-mapex.xml FORM 4 X0303 4 2010-05-11 1 0001401923 MAP Pharmaceuticals, Inc. MAPP 0001029160 SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 31ST FLOOR NEW YORK NY 10106 0 0 1 0 0000900203 SOROS GEORGE 888 SEVENTH AVE 31ST FLR NEW YORK NY 10106 0 0 1 0 0001387524 Soros Robert C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE, 31ST FLOOR NEW YORK NY 10106 0 0 1 0 0001387590 SOROS JONATHAN T ALLAN C/O SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE, 31ST FLOOR NEW YORK NY 10106 0 0 1 0 Common Stock 2010-05-11 4 J 0 777120 D 2049049 I See Footnotes All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), SFM Participation, L.P ("SFM Participation"), a managing member of Perseus-Soros Partners LLC, the general partner of Perseus-Soros, Biotech Management Partners, LLC ("Biotech Management Partners") and Quantum Industrial Partners, LDC ("QIP"). On May 11, 2010, Perseus-Soros distributed 1,000,000 shares of the Issuers Common Stock pro rata to its partners for no consideration and certain partners of Perseus-Soros have made subsequent pro rata distributions to their respective partners or members for no consideration (collectively, the "Distributions"). As a result of the Distributions, SFM Participation now holds 1,114 shares of the Issuers Common Stock, Biotech Management Partners, LLC now holds 89 shares of the Issuers Common Stock, QIP now holds 221,677 shares of the Issuers Common Stock and Perseus-Soros now holds 1,826,169 shares of the Issuers Common Stock. SFM Participation is a managing member of Biotech Management Partners. SFM AH, LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. The sole manager of SFM AH is Soros Fund Management LLC ("SFM LLC"). SFM LLC also serves as the principal investment manager to QIP. Mr. George Soros ("Mr. Soros") serves as Chairman of SFM LLC, Mr. Robert Soros ("Robert Soros") serves as Deputy Chairman of SFM LLC and Mr. Jonathan Soros ("Jonathan Soros") serves as President and Deputy Chairman of SFM LLC. (4) Jodye M. Anzalotta is signing in her capacity as Ass't General Counsel of Soros Fund Management LLC. (5) Jodye M. Anzalotta is signing in her capacity as Attorney-in-Fact for Mr. George Soros. (6) Jodye M. Anzalotta is signing in her capacity as Attorney-in-Fact for Mr. Robert Soros. (7) Jodye M. Anzalotta is signing in her capacity as Attorney-in-Fact for Mr. Jonathan Soros. /s/ Jodye M. Anzalotta, Assistant General Counsel (4) 2010-05-13 /s/ Jodye M. Anzalotta, Assistant General Counsel (5) 2010-05-13 /s/ Jodye M. Anzalotta, Assistant General Counsel (6) 2010-05-13 /s/ Jodye M. Anzalotta, Assistant General Counsel (7) 2010-05-13 EX-99 2 ex99-1_sfmllc.htm EXHIBIT 99.1

Exhibit 99.1

 

Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Mr. Soros, Robert Soros, Jonathan Soros and SFM LLC may be deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros, Perseus-Soros Partners, SFM Participation, Biotech Management Partners, LLC and QIP only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of each such entity. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Mr. Soros, Robert Soros, Jonathan Soros or SFM LLC, is for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros, Perseus-Soros Partners, SFM Participation, Biotech Management Partners, LLC and QIP in excess of such amount.

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----